TrialJournal of the American Heart Association2026

Add-On PCSK9 Inhibitor Therapy for Acute Stroke Attributable to Intracranial Atherosclerosis: A Randomized Clinical Trial.

Yi-Ting Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.